Treffer: Engineering Pichia pastoris Strains Using CRISPR/Cas9 Technologies: The Basic Protocol.
Original Publication: Clifton, N.J. : Humana Press,
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823. https://doi.org/10.1126/science.1231143. (PMID: 10.1126/science.1231143232877183795411)
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821. https://doi.org/10.1126/science.1225829. (PMID: 10.1126/science.1225829227452496286148)
Raschmanová H, Weninger A, Glieder A, Kovar K, Vogl T (2018) Implementing CRISPR-Cas technologies in conventional and non-conventional yeasts: current state and future prospects. Biotechnol Adv 36:641–665. https://doi.org/10.1016/j.biotechadv.2018.01.006. (PMID: 10.1016/j.biotechadv.2018.01.00629331410)
Weninger A, Hatzl AM, Schmid C, Vogl T, Glieder A (2015) Combinatorial optimization of CRISPR/Cas9 expression enables precision genome engineering in the methylotrophic yeast Pichia pastoris. J Biotechnol 235:139–149. https://doi.org/10.1016/j.jbiotec.2016.03.027. (PMID: 10.1016/j.jbiotec.2016.03.027)
Weninger A, Fischer JE, Raschmanová H, Kniely C, Vogl T, Glieder A (2018) Expanding the CRISPR/Cas9 toolkit for Pichia pastoris with efficient donor integration and alternative resistance markers. J Cell Biochem 119:3183–3198. https://doi.org/10.1002/jcb.26474. (PMID: 10.1002/jcb.2647429091307)
Fischer JE, Glieder A (2022) CRISPR/Cas9 tool kit for efficient and targeted insertion/deletion mutagenesis of the Komagataella phaffii (Pichia pastoris). Genome Methods Mol Biol 2513:121–133. https://doi.org/10.1007/978-1-0716-2399-2_8. (PMID: 10.1007/978-1-0716-2399-2_835781203)
Weitere Informationen
The CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats, CRISPR-associated protein 9) system has become a commonly used tool for genome editing and metabolic engineering. For Komagataella phaffii, commercialized as Pichia pastoris, the CRISPR/Cas9 protocol for genome editing was established in 2016 and since then has been employed to facilitate genetic modifications such as markerless gene disruptions and deletions as well as to enhance the efficiency of homologous recombination.In this chapter, we describe a robust basic protocol for CRISPR-based genome editing, demonstrating near 100% targeting efficiency for gene inactivation via a frameshift mutation. As described in other chapters of this volume, CRISPR/Cas9 technologies for use in P. pastoris have been further optimized for various specific purposes.
(© 2026. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.)